Smaller medtechs suffer, but not from Covid-19

The improving pandemic situation in the West has been the main driver of the largest share price rises among small and mid-cap medical device companies in the first half of the year. Groups whose products are used in elective surgeries are soaring on increased demand as lockdown measures lift.